These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Long-term treatment with neuroleptics in psychiatry. Shepherd M; Watt DC Curr Dev Psychopharmacol; 1977; 4():215-47. PubMed ID: 23248 [No Abstract] [Full Text] [Related]
10. Long-acting injectable olanzapine can give rise to a condition consistent with central anticholinergic syndrome. Skomedal T; Hanem S; Dybvik T; Ilner SO Tidsskr Nor Laegeforen; 2013 Nov; 133(21):2238-9. PubMed ID: 24226327 [No Abstract] [Full Text] [Related]
11. Impact of orally disintegrating olanzapine on use of intramuscular antipsychotics, seclusion, and restraint in an acute inpatient psychiatric setting. Simpson JR; Thompson CR; Beckson M J Clin Psychopharmacol; 2006 Jun; 26(3):333-5. PubMed ID: 16702903 [No Abstract] [Full Text] [Related]
12. Factors affecting compliance with depot injection treatment in the community. Tunnicliffe S; Harrison G; Standen PJ Soc Psychiatry Psychiatr Epidemiol; 1992 Oct; 27(5):230-3. PubMed ID: 1359653 [TBL] [Abstract][Full Text] [Related]
13. Late-onset neuroleptic malignant syndrome in a patient using olanzapine. Kunz M; Gomes FA; Tramontina JF; Kapczinski F J Clin Psychopharmacol; 2007 Jun; 27(3):303-4. PubMed ID: 17502780 [No Abstract] [Full Text] [Related]
14. Reversible delayed onset olanzapine-associated leukopenia and neutropenia in a clozapine-naive patient on concomitant depot antipsychotic. Thinn SS; Liew E; May AL; Chua HC; Sim K J Clin Psychopharmacol; 2007 Aug; 27(4):394-5. PubMed ID: 17632225 [No Abstract] [Full Text] [Related]
15. A case of akathisia after switching from branded to generic high-dose olanzapine. Goldberg JF J Clin Psychiatry; 2012 Apr; 73(4):497. PubMed ID: 22579148 [No Abstract] [Full Text] [Related]
16. Olanzapine and delirium: lesson from clinical practice. Singh D; Forlano R Aust N Z J Psychiatry; 2008 May; 42(5):433-4. PubMed ID: 18499932 [No Abstract] [Full Text] [Related]
17. Safety and antipsychotic efficacy of "forced" intramuscular olanzapine over five days: a case report. Marks DM; Conner MJ; Pae CU Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):386-7. PubMed ID: 19166898 [No Abstract] [Full Text] [Related]
18. [Post-injection syndrome after depot injection of olanzapine]. Wilms EB; van der Velden MT; van Essen FH; ten Brink C Ned Tijdschr Geneeskd; 2014; 159():A7885. PubMed ID: 25589277 [TBL] [Abstract][Full Text] [Related]
19. Sustained improvement of clinical outcome with risperidone long-acting injectable in psychotic patients previously treated with olanzapine. Gastpar M; Masiak M; Latif MA; Frazzingaro S; Medori R; Lombertie ER J Psychopharmacol; 2005 Sep; 19(5 Suppl):32-8. PubMed ID: 16144784 [TBL] [Abstract][Full Text] [Related]
20. Relationship between smoking and psychotic symptoms in a patient treated with oral olanzapine. A case report. Leal-Micharet A; Vaz-Leal FJ; Méndez-Salguero MJ; Méndez-Sánchez F; Baltasar-Tello I; Gómez-Tovar B; Gajardo-Galán V Actas Esp Psiquiatr; 2014; 42(5):263-6. PubMed ID: 25179099 [No Abstract] [Full Text] [Related] [Next] [New Search]